Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Natural full-spectrum tocotrienols

Full Spectrum Tocotrienols (EVNol SupraBio) · also known as Tocotrienols, Red palm oil extract, EVNol, Tocotrienols

Tocotrienols can modulate inflammatory signaling and nerve-related pathways in cell and animal models. In human trials, oxidation markers such as malondialdehyde fell somewhat and serum NGF rose, but human findings on effects in the brain and on cholesterol lowering are not consistent.

Typical dose: Pure tocotrienols (α/β/γ/δ) 50–200 mg/day, taken with a meal
Absorption and forms: α-Tocopherol competes with tocotrienols for the hepatic α-tocopherol transfer protein (α-TTP), so high-dose regular vitamin E should not be taken at the same time. Self-microemulsifying formulations help absorption, but they do not fully remove the influence of bile or food, and absorption and retention differ markedly between isomers.

Clinical uses and human evidence

Fatty liver and liver enzymes

BeneficialGrade C · Preliminary evidence
Studies (1)
  1. Magosso 2013 · Nutr J · RCT · n=87 — Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trial

Blood sugar and insulin resistance

Mixed resultsGrade B · Moderate evidence
Studies (1)
  1. Phang 2023 · Adv Nutr · Meta-analysis — Effects of Tocotrienol-Rich Fraction Supplementation in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Inflammation markers (such as CRP)

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Khor 2021 · PLoS One · Meta-analysis — Effects of tocotrienols supplementation on markers of inflammation and oxidative stress: A systematic review and meta-analysis of randomized controlled trials
  2. Phang 2023 · Adv Nutr · Meta-analysis — Effects of Tocotrienol-Rich Fraction Supplementation in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Peripheral neuropathy (numbness and tingling)

No benefitGrade B · Moderate evidence
Studies (1)
  1. Hor 2018 · JAMA Neurol · RCT · n=300 — Efficacy of Oral Mixed Tocotrienols in Diabetic Peripheral Neuropathy: A Randomized Clinical Trial

High LDL cholesterol

No benefitGrade B · Moderate evidence
Studies (1)
  1. Zuo 2020 · Complement Ther Med · Meta-analysis — The effects of tocotrienol supplementation on lipid profile: A meta-analysis of randomized controlled trials

High triglycerides

No benefitGrade B · Moderate evidence
Studies (1)
  1. Zuo 2020 · Complement Ther Med · Meta-analysis — The effects of tocotrienol supplementation on lipid profile: A meta-analysis of randomized controlled trials

Mechanisms of action

Direct free radical trapping and chemical quenching

★★★☆☆Mechanism evidence: grade BPrimary target

Tocotrienols have antioxidant chemical activity in lipid environments and may help inhibit membrane lipid peroxidation. Malondialdehyde and similar markers fell in humans, but these markers are not specific evidence of direct free-radical scavenging, and neuroprotection should not be attributed entirely to this activity.

References (2)
  1. Pervez 2020 · RCT: malondialdehyde and other markers fell in the δ-tocotrienol group
  2. Khanna 2003 · Neuronal cell study: α-tocotrienol affected glutamate-related 12-LOX signaling, and this effect cannot simply be attributed to direct free-radical scavenging

Inhibition of NF-κB / AP-1, the master switches of pro-inflammatory transcription

★★★☆☆Mechanism evidence: grade CSecondary target

In cell studies, γ- and δ-tocotrienols can inhibit IκBα phosphorylation, and animal studies at higher doses also found changes in NF-κB signaling. Whether this target is inhibited in humans has not been measured, and general inflammation markers cannot stand in for that measurement.

References (2)
  1. Ahn 2007 · Cell study: γ-tocotrienol inhibited IκBα phosphorylation and NF-κB signaling
  2. 2013 study · Mouse study: higher-dose δ-tocotrienol affected NF-κB signaling in pancreatic tissue

Neurotrophic factor synthesis and TrkB/A receptor activation

★★☆☆☆Mechanism evidence: grade ASecondary target

In a randomized trial in patients with diabetic peripheral neuropathy, serum NGF rose after taking a tocotrienol-rich formulation (400 mg daily). This result does not establish that BDNF or Trk receptors were activated in the brain, and it cannot be extended to lower doses.

References (2)
  1. Ng 2020 · RCT: serum NGF rose after a tocotrienol-rich formulation in patients with diabetic peripheral neuropathy
  2. Khanna 2003 · Cell study: 12-LOX regulation and the NGF and BDNF pathways are distinct mechanisms and should not be conflated

Safety and drug interactions

With anticoagulants such as warfarin, there may be a mild additive antiplatelet effect. Watch for bleeding and monitor INR, and do not limit this precaution to people taking very high doses. Tolerability at usual doses is generally good.

Additive bleeding risk

A member of the vitamin E family with antiplatelet activity. Each of these has a mild antiplatelet or fibrinolytic effect. Alone, the effect is usually small, but when several are combined, the tendency to bleed becomes more noticeable. Stop them 1–2 weeks before surgery or a tooth extraction, and watch for gum bleeding or more bruising.

Open in the interactive app ›